Marqibo: payments to doctors
Payments that named Marqibo as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $82K
- Providers
- 365
- Transactions
- 452
- Average per transaction
- $182
The per-transaction average — $182 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 365 providers the average total is $226, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Spectrum Pharmaceuticals Inc. | $75,332 | 91.3% |
| Aurobindo Pharma USA, Inc. | $4,840 | 5.9% |
| Acrotech Biopharma LLC | $2,296 | 2.8% |